Identifiers
Functions
Nanocellulose is considered safe under current use and concentration practices, with an acute inhalation LC50 in rats exceeding 5,800 mg/m³/4h, indicating low acute toxicity. However, it can cause irritation to the eyes, skin, and mucous membranes, and the respiratory system is a target organ. These findings support its use in formulations where exposure is controlled, but they do not eliminate the need for standard safety assessments. The absence of GHS classifications and exposure limits means that formal hazard labeling and occupational exposure thresholds are not established from the available evidence.
The toxicology data indicate low acute toxicity but notable irritation potential, which should be interpreted as a need for handling precautions rather than a systemic hazard. The lack of GHS classifications means that formal hazard communication categories are not defined, so the irritation and target organ effects should be used as the basis for precautionary statements. In a formulation context, this suggests that nanocellulose can be used safely with appropriate labeling for eye, skin, and respiratory irritation, but without a GHS classification, regulatory classification cannot be assumed.
The material exposure routes are inhalation and skin/eye contact, with the respiratory system, eyes, and skin identified as target organs. The acute inhalation LC50 in rats is greater than 5,800 mg/m³/4h, indicating a low risk from a single high-dose exposure, but repeated or prolonged contact may lead to irritation. For product development, this means that dust generation during handling should be minimized, and contact with eyes and skin should be avoided. The lack of exposure limit data prevents quantitative risk characterization for chronic occupational exposure.
Relevant risk-management measures include controlling inhalation exposure and preventing skin and eye contact, as these are the primary exposure routes. Given the irritation potential, use of personal protective equipment such as gloves, safety goggles, and respiratory protection is advisable when handling the material in powder form. In manufacturing, local exhaust ventilation and dust suppression can reduce airborne exposure. The absence of established exposure limits means that these controls should be implemented based on good industrial hygiene practice rather than regulatory thresholds.
Before finalizing safety decisions, the absence of GHS hazard classifications and occupational exposure limits should be addressed, as these are critical for regulatory compliance and risk management. Additionally, chronic toxicity and repeated-dose exposure data are not available, which limits the ability to assess long-term health risks. For cosmetic applications, the regulatory status of nanocellulose is not directly established; the available data refer to cellulose, which is listed as an active ingredient with functions such as absorbent and bulking, but no specific restrictions. These gaps should be filled with targeted studies or regulatory submissions.